Evidence map›Paper›PMID 31006093›Full record

ReviewNeurochemical research2020

Spinal Cord Injury: Animal Models, Imaging Tools and the Treatment Strategies.

Dasa Cizkova, Adriana-Natalia Murgoci, Veronika Cubinkova, Filip Humenik, Zuzana Mojzisova, Marcela Maloveska, Milan Cizek, Isabelle Fournier, Michel Salzet

Abstract readReview
PubMed Publisher
In one paragraph

Review in Neurochemical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Dasa CizkovaInstitute of Neuroimmunology, Slovak Academy of Sciences, Dúbravská cesta 9, 845 10, Bratislava, Slovakia. cizkova.dasa@gmail.com.ORCID http://orcid.org/0000-0002-2504-3993
Adriana-Natalia MurgociInstitute of Neuroimmunology, Slovak Academy of Sciences, Dúbravská cesta 9, 845 10, Bratislava, Slovakia.ORCID http://orcid.org/0000-0002-4492-6804
Veronika CubinkovaInstitute of Neuroimmunology, Slovak Academy of Sciences, Dúbravská cesta 9, 845 10, Bratislava, Slovakia.
Filip HumenikDepartment of Anatomy, Histology and Physiology, University of Veterinary Medicine and Pharmacy in Košice, Komenského 73, 041 81, Kosice, Slovakia.
Zuzana MojzisovaDepartment of Anatomy, Histology and Physiology, University of Veterinary Medicine and Pharmacy in Košice, Komenského 73, 041 81, Kosice, Slovakia.
Marcela MaloveskaDepartment of Anatomy, Histology and Physiology, University of Veterinary Medicine and Pharmacy in Košice, Komenského 73, 041 81, Kosice, Slovakia.
Milan CizekDepartment of Epizootology and Parasitology, University of Veterinary Medicine and Pharmacy in Košice, Komenského 73, 041 81, Kosice, Slovakia.
Isabelle FournierInserm, U-1192-Laboratoire Protéomique, Réponse Inflammatoire et Spectrométrie de Masse-PRISM, Université de Lille, 59000, Lille, France.ORCID http://orcid.org/0000-0003-1096-5044
Michel SalzetInserm, U-1192-Laboratoire Protéomique, Réponse Inflammatoire et Spectrométrie de Masse-PRISM, Université de Lille, 59000, Lille, France.ORCID http://orcid.org/0000-0003-4318-0817
University of Veterinary Medicine in Košice · SKInserm · FRInstitute of Chemistry of the Slovak Academy of Sciences · SKSlovak Academy of Sciences · SK

Funding

Agentúra na Podporu Výskumu a Vývoja (SK) APVV 15-0613ERANET ERANET-AxonRepairL'Enseignement Supérieur et de la Recherche, INSERM INSERMSIRIC ONCOLille Grant INCD a-DGOS Inserm 6041aaVedecká Grantová Agentúra MŠVVaŠ SR a SAV VEGA 2/0146/19VEGA 1/0571/17
6 · The paper itself

Abstract

Spinal cord injury (SCI) often leads to irreversible neuro-degenerative changes with life-long consequences. While there is still no effective therapy available, the results of past research have led to improved quality of life for patients suffering from partial or permanent paralysis. In this review we focus on the need, importance and the scientific value of experimental animal models simulating SCI in humans. Furthermore, we highlight modern imaging tools determining the location and extent of spinal cord damage and their contribution to early diagnosis and selection of appropriate treatment. Finally, we focus on available cellular and acellular therapies and novel combinatory approaches with exosomes and active biomaterials. Here we discuss the efficacy and limitations of adult mesenchymal stem cells which can be derived from bone marrow, adipose tissue or umbilical cord blood and its Wharton's jelly. Special attention is paid to stem cell-derived exosomes and smart biomaterials due to their special properties as a delivery system for proteins, bioactive molecules or even genetic material.

Indexed as

Disease Models, AnimalAnimalsHumansMagnetic Resonance ImagingNeuroimagingNeurosurgical ProceduresPositron-Emission TomographySpinal Cord InjuriesStem Cell TransplantationTomography, X-Ray ComputedTreatment OutcomeAnimal modelsBiomaterialsExosomesImagingSpinal cord injuryStem cells

Identifiers

PMID31006093
OpenAlexW2938366670

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.